Mendelian randomization for studying the effects of perturbing drug targets. (2021)

First Author: Gill D

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.12688/wellcomeopenres.16544.2

PubMed Identifier: 33644404

Publication URI: http://europepmc.org/abstract/MED/33644404

Type: Journal Article/Review

Volume: 6

Parent Publication: Wellcome open research

ISSN: 2398-502X